Open AccessImmune checkpoint inhibitors induced colitis, stay vigilant: A case report
Author(s) -
Suha Abu Khalaf,
Abdulmajeed Albarrak,
Mohammad S. Yousef,
Veysel Tahan
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i6.699
Subject(s) - medicine , ipilimumab , discontinuation , nivolumab , immunotherapy , colitis , abdominal pain , intensive care medicine , surgery , cancer
Colitis is one of the immune-related side effects of immunotherapy. Usually, such type of side effect was reported to develop within a few weeks of treatment initiation, our case started within a few days.